high priced drugs

Results 1 - 1 of 1Sort Results By: Published Date | Title | Company Name
By: IBM Watson Health     Published Date: Dec 20, 2018
In this webinar, experts discuss how data and analytics can be applied to improve health program outcomes and how social determinants of health affect risk. It includes a case study on how the application of advanced analytic methods helped to decipher the impact of high-priced specialty drugs on the overall population. The experts also address how artificial intelligence can drive better decision-making, improve population health and cut costs.
Tags : government, health and human services, artificial intelligence, data, cognitive insights, long-term care, case study, analytics, social program management, spm, healthcare technology, high-priced drugs, specialty drugs, population health
     IBM Watson Health
Search White Papers      

Add White Papers

Get your white papers featured in the Energy Efficiency Markets White Paper Library contact: Kevin@EnergyEfficiencyMarkets.com